| 000 | 01431 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517130631.0 | ||
| 264 | 0 | _c20180924 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(16)32454-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDenkert, Carsten | |
| 245 | 0 | 0 |
_aMolecular alterations in triple-negative breast cancer-the road to new treatment strategies. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJun 2017 |
||
| 300 |
_a2430-2442 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Profiling _xmethods |
| 650 | 0 | 4 |
_aGenomics _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocytes, Tumor-Infiltrating _ximmunology |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xmethods |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aNeoadjuvant Therapy _xmethods |
| 650 | 0 | 4 |
_aTriple Negative Breast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aUbiquitin-Protein Ligases _xgenetics |
| 700 | 1 | _aLiedtke, Cornelia | |
| 700 | 1 | _aTutt, Andrew | |
| 700 | 1 | _avon Minckwitz, Gunter | |
| 773 | 0 |
_tLancet (London, England) _gvol. 389 _gno. 10087 _gp. 2430-2442 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(16)32454-0 _zAvailable from publisher's website |
| 999 |
_c26684611 _d26684611 |
||